Data search
Results for MligTC455_15215
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_15215 | 22 | 0.46 | Mlig455_037928 | Neo: - Age: - |
CHRNA9 | Mlig455_037928 {REF} {Length: 2079} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=180.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=57.1]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=221, Expect=7e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=9e-64]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=222, Expect=1e-65]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=219, Expect=3e-64]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=214, Expect=7e-63]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=228, Expect=2e-65]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=221, Expect=6e-65]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=214, Expect=1e-62]} {RNA1310_88831} |
Cumulative graph for MligTC455_15215
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -2.895 | 0.891 | 0.99980 | 1.00000 | |
| RegionR2 | 1.294 | 0.891 | 0.99985 | 1.00000 | |
| RegionR3 | 1.424 | 0.891 | 0.99988 | 1.00000 | |
| RegionR4 | 1.2 | 0.891 | 0.09236 | 0.29149 | |
| RegionR5 | -0.234 | 0.891 | 0.99966 | 1.00000 | |
| RegionR6 | -1.943 | 0.891 | 0.99985 | 1.00000 | |
| RegionR7 | 2.087 | 0.891 | 1.00000 | 1.00000 | |
| RegionR8 | -0.933 | 0.891 | 0.99993 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -0.372 | 0.891 | 0.99968 | 1.00000 | |
| RegenerationR2 | 0.018 | 0.891 | 0.33613 | 0.77196 | |
| RegenerationR3 | -2.368 | 0.891 | 0.71190 | 0.95199 | |
| RegenerationR4 | -2.84 | 0.891 | 0.09370 | 0.47701 | |
| RegenerationR5 | -1.746 | 0.891 | 0.99994 | 1.00000 | |
| RegenerationR6 | 1.327 | 0.891 | 1.00000 | 1.00000 | |
| RegenerationBL | -2.853 | 0.891 | 0.99992 | 1.00000 | |
| RegenerationTP | -2.995 | 0.891 | 0.99994 | 1.00000 |
Genes with expression patterns similar to MligTC455_15215
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_15215 | 22 | 0.46 | Mlig455_037928 | Neo: - Age: - |
CHRNA9 | 3 | - | - | 1.000 | 1.000 | 1.000 | - | Mlig455_037928 {REF} {Length: 2079} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=180.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=57.1]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=221, Expect=7e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=9e-64]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=222, Expect=1e-65]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=219, Expect=3e-64]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=214, Expect=7e-63]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=228, Expect=2e-65]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=221, Expect=6e-65]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=214, Expect=1e-62]} {RNA1310_88831} |
| 2. | MligTC455_36464 | 50 | 1.04 | Mlig455_043920 | Neo: - Age: - |
2.682 | - | - | 0.965 | 0.743 | 0.974 | - | Mlig455_043920 {REF} {Length: 2693} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=19.4]} {Dmel: FBgn0029768, SPR, Sex peptide receptor, [Score=52.8, Expect=6e-07]} {Celegans: WBGene00009629, sprr-2, Sex Peptide Receptor (Drosophila) Related, [Score=51.6, Expect=1e-06]} {Smed: dd_Smed_v6_11997_0_1, dd_Smed_v6_11997_0_1, [Score=130, Expect=4e-33]} {RNA1310_82024} {RNA815_18750} | |
| 3. | MligTC455_23543 | 79 | 1.65 | Mlig455_021851 | Neo: - Age: - Region-enriched R2: 5.153/0.00077 |
MAP3K19 | 2.455 | - | - | 0.737 | 0.752 | 0.966 | - | Mlig455_021851 {REF} {Length: 7454} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=226.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=217.3]; Ankyrin repeats (3 copies) [PF12796.9, score=113.8]; Ankyrin repeats (many copies) [PF13637.8, score=82.7]; Ankyrin repeats (many copies) [PF13857.8, score=77.3]; F5/8 type C domain [PF00754.27, score=56.3]; Ankyrin repeat [PF00023.32, score=55.9]; Ankyrin repeat [PF13606.8, score=49.9]; ABC1 atypical kinase-like domain [PF03109.18, score=28.7]} {Human: ENSG00000176601, MAP3K19, mitogen-activated protein kinase kinase kinase 19, [Score=159, Expect=2e-40]} {Mouse: ENSMUSG00000051590, Map3k19, mitogen-activated protein kinase kinase kinase 19, [Score=164, Expect=3e-42]} {Dmel: FBgn0266465, GckIII, Germinal centre kinase III, [Score=146, Expect=1e-35]} {Celegans: WBGene00001526, gck-1, Germinal center kinase 1, [Score=139, Expect=2e-33]} {Smed: dd_Smed_v6_10339_0_1, dd_Smed_v6_10339_0_1, [Score=153, Expect=2e-37]} {RNA1509_46581} {RNA1310_9191} {RNA815_12161} |
| 4. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 2.432 | - | - | 0.773 | 0.704 | 0.955 | - | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
| 5. | MligTC455_15949 | 37 | 0.76 | Mlig455_059880 | Neo: - Age: - |
1.922 | - | - | - | 0.946 | 0.976 | - | Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903} | |
| 6. | MligTC455_23977 | 63 | 1.31 | Mlig455_012689 | Neo: - Age: - Regeneration-downregulated R5: -6.245 Regeneration-depleted R5: -6.245 |
DRD2 | 1.914 | - | - | - | 0.948 | 0.966 | - | Mlig455_012689 {REF} {Length: 2124} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=191.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=32.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.4]} {Human: ENSG00000149295, DRD2, dopamine receptor D2, [Score=170, Expect=1e-46]} {Mouse: ENSMUSG00000032259, Drd2, dopamine receptor D2, [Score=168, Expect=4e-46]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [RH, Score=160, Expect=4e-43]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=159, Expect=2e-42]} {Smed: dd_Smed_v6_27884_0_1, dd_Smed_v6_27884_0_1, [Score=198, Expect=7e-57]} {RNA1310_28840} {RNA815_30584} |
| 7. | MligTC455_38065 | 47 | 0.98 | Mlig455_054213 | Neo: - Age: - |
KREMEN2 | 1.89 | - | - | - | 0.915 | 0.975 | - | Mlig455_054213 {REF} {Length: 924} {Pfam: WSC domain [PF01822.21, score=68.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=1e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=52.0, Expect=1e-07]} {RNA1509_53783} {RNA1310_43773} {RNA815_23638} |
| 8. | MligTC455_14057 | 47 | 0.97 | Mlig455_050243 | Neo: - Age: - |
GRIK1 | 1.882 | - | - | - | 0.916 | 0.966 | - | Mlig455_050243 {REF} {Length: 3866} {Pfam: Ligand-gated ion channel [PF00060.28, score=173.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=119.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=62.8]; Receptor family ligand binding region [PF01094.30, score=53.1]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=18.7]} {Human: ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=579, Expect=0.0]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=571, Expect=0.0]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=558, Expect=0.0]} {Mouse: ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=580, Expect=0.0]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=570, Expect=0.0]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=559, Expect=0.0]} {Dmel: FBgn0038837, CG3822, [Score=528, Expect=9e-173]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=422, Expect=6e-133]} {Smed: dd_Smed_v6_8816_0_1, dd_Smed_v6_8816_0_1, [Score=605, Expect=0.0]} {RNA1509_25923} {RNA1310_74435} {RNA815_4408.2} |
| 9. | MligTC455_09457 | 18 | 0.37 | Mlig455_030003 | Neo: - Age: - |
1.881 | - | - | - | 0.902 | 0.979 | - | Mlig455_030003 {REF} {Length: 1601} {RNA1509_44134} {RNA1310_63608.1} {RNA815_45870} | |
| 10. | MligTC455_53199 | 76 | 1.58 | Mlig455_035187 | Neo: - Age: Up-Down-Down |
1.88 | - | - | - | 0.889 | 0.991 | - | Mlig455_035187 {REF} {Length: 4248} {Pfam: MyTH4 domain [PF00784.19, score=60.4]} {Smed: dd_Smed_v6_19214_0_1, dd_Smed_v6_19214_0_1, [RH, Score=172, Expect=1e-46]} {RNA1310_70974} {RNA815_46536} | |
| 11. | MligTC455_15022 | 16 | 0.33 | Mlig455_040949 | Neo: - Age: - |
PRKAR2B | 1.876 | - | - | 0.908 | - | 0.968 | - | Mlig455_040949 {REF} {Length: 1526} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=128.5]} {Human: ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=191, Expect=3e-57]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=191, Expect=3e-57]; ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=190, Expect=5e-57]} {Mouse: ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=189, Expect=1e-56]; ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=188, Expect=2e-56]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=217, Expect=5e-68]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=130, Expect=3e-35]} {Smed: dd_Smed_v6_2902_0_1, dd_Smed_v6_2902_0_1, [Score=187, Expect=8e-57]} {RNA1310_91044} {RNA815_60658} |
| 12. | MligTC455_44766 | 87 | 1.81 | Mlig455_054070 | Neo: - Age: - Region-enriched R2: 8.262/0.00000 |
1.87 | - | - | - | 0.885 | 0.985 | - | Mlig455_054070 {REF} {Length: 1746} {RNA1310_24217} {RNA815_39411} | |
| 13. | MligTC455_51557 | 57 | 1.19 | Mlig455_038195 | Neo: - Age: Down-Up-Up |
ISL1 | 1.866 | - | - | 0.877 | - | 0.989 | - | Mlig455_038195 {REF} {Length: 2149} {Pfam: LIM domain [PF00412.24, score=91.4]; Homeodomain [PF00046.31, score=55.3]; Homeobox KN domain [PF05920.13, score=23.4]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [Score=180, Expect=9e-52]; ENSG00000159556, ISL2, ISL LIM homeobox 2, [Score=173, Expect=3e-49]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [Score=180, Expect=6e-52]; ENSMUSG00000032318, Isl2, insulin related protein 2 (islet 2), [Score=175, Expect=4e-50]} {Dmel: FBgn0003896, tup, tailup, [Score=151, Expect=3e-40]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=303, Expect=1e-97]} {RNA1310_54855} {RNA815_46288} |
| 14. | MligTC455_26411 | 55 | 1.14 | Mlig455_024911 | Neo: - Age: - |
1.863 | - | - | - | 0.882 | 0.981 | - | Mlig455_024911 {REF} {Length: 2411} {Pfam: SH3 domain [PF00018.30, score=28.9]; Variant SH3 domain [PF14604.8, score=22.2]; Variant SH3 domain [PF07653.19, score=22.1]} {Smed: dd_Smed_v6_8729_0_1, dd_Smed_v6_8729_0_1, [RH, Score=60.1, Expect=5e-10]} {RNA1310_32104} {RNA815_32970} | |
| 15. | MligTC455_45898 | 87 | 1.82 | Mlig455_058293 | Neo: - Age: - |
CUX2 | 1.858 | - | - | 0.896 | - | 0.962 | - | Mlig455_058293 {REF} {Length: 4328} {Pfam: CUT domain [PF02376.17, score=197.2]; Homeodomain [PF00046.31, score=53.8]; Homeobox KN domain [PF05920.13, score=29.1]} {Human: ENSG00000111249, CUX2, cut like homeobox 2, [Score=144, Expect=3e-34]} {Mouse: ENSMUSG00000042589, Cux2, cut-like homeobox 2, [Score=148, Expect=1e-35]} {Dmel: FBgn0004198, ct, cut, [Score=123, Expect=4e-28]} {Celegans: WBGene00000464, ceh-44, Homeobox protein cut-like ceh-44, [RH, Score=142, Expect=4e-34]} {Smed: dd_Smed_v6_13843_0_1, dd_Smed_v6_13843_0_1, [Score=125, Expect=6e-29]} {RNA1310_11859} {RNA815_40841} |
| 16. | MligTC455_34925 | 183 | 3.82 | Mlig455_012715 | Neo: - Age: - |
CDKL1 | 1.857 | - | - | - | 0.889 | 0.968 | - | Mlig455_012715 {REF} {Length: 2370} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=250.2]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=120.6]; RIO1 family [PF01163.24, score=23.0]; ABC1 atypical kinase-like domain [PF03109.18, score=20.8]; Haspin like kinase domain [PF12330.10, score=20.4]; Kinase-like [PF14531.8, score=19.4]} {Human: ENSG00000100490, CDKL1, cyclin dependent kinase like 1, [RH, Score=437, Expect=3e-153]; ENSG00000205111, CDKL4, cyclin dependent kinase like 4, [RH, Score=424, Expect=2e-147]} {Mouse: ENSMUSG00000020990, Cdkl1, cyclin-dependent kinase-like 1 (CDC2-related kinase), [RH, Score=437, Expect=2e-153]; ENSMUSG00000033966, Cdkl4, cyclin-dependent kinase-like 4, [RH, Score=432, Expect=2e-151]} {Dmel: FBgn0031730, CG7236, [RH, Score=384, Expect=3e-131]} {Celegans: WBGene00012779, cdkl-1, Cyclin-Dependent Kinase-Like, [RH, Score=388, Expect=3e-132]} {Smed: dd_Smed_v6_9353_0_1, dd_Smed_v6_9353_0_1, [RH, Score=472, Expect=5e-167]} {RNA1509_44617} {RNA1310_15038, RNA1509_44617} {RNA1509_44617, RNA815_6379} |
| 17. | MligTC455_44159 | 80 | 1.67 | Mlig455_019040, Mlig455_055663 | Neo: - Age: Down-Up-Up |
ADRB1, GALR3 | 1.856 | - | - | - | 0.875 | 0.981 | - | Mlig455_019040 {REF} {Length: 1804} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=31.3]} {Human: ENSG00000043591, ADRB1, adrenoceptor beta 1, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=47.8, Expect=1e-05]} {Dmel: FBgn0038874, ETHR, [Score=49.3, Expect=3e-06]} {Celegans: WBGene00017661, frpr-6, FMRFamide Peptide Receptor family, [Score=54.3, Expect=5e-08]} {Smed: dd_Smed_v6_19933_0_1, dd_Smed_v6_19933_0_1, [RH, Score=124, Expect=9e-33]} {RNA1310_47955} {RNA815_45615} Mlig455_055663 {REF} {Length: 1667} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.2]} {Human: ENSG00000128310, GALR3, galanin receptor 3, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [Score=103, Expect=6e-25]} {RNA1310_86586} {RNA815_45615} |
| 18. | MligTC455_44395 | 179 | 3.73 | Mlig455_054597, Mlig455_067604 | Neo: - Age: Up-Down-Down |
SLC8A1 | 1.856 | - | - | 0.873 | - | 0.983 | - | Mlig455_054597 {REF} {Length: 3516} {TRANSSPLICED} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=162.7]; Calx-beta domain [PF03160.16, score=142.8]; C-terminal extension of sodium/calcium exchanger domain [PF16494.7, score=23.2]; Domain of unknown function (DUF4843) [PF16132.7, score=18.7]} {Human: ENSG00000183023, SLC8A1, solute carrier family 8 member A1, [Score=518, Expect=1e-170]; ENSG00000100678, SLC8A3, solute carrier family 8 member A3, [Score=497, Expect=9e-163]} {Mouse: ENSMUSG00000054640, Slc8a1, solute carrier family 8 (sodium/calcium exchanger), member 1, [Score=513, Expect=1e-168]; ENSMUSG00000079055, Slc8a3, solute carrier family 8 (sodium/calcium exchanger), member 3, [Score=501, Expect=1e-164]} {Dmel: FBgn0013995, Calx, Na/Ca-exchange protein, [Score=510, Expect=7e-168]} {Celegans: WBGene00003568, ncx-3, Na/Ca eXchangers, [Score=532, Expect=7e-178]} {Smed: dd_Smed_v6_3303_0_1, dd_Smed_v6_3303_0_1, [Score=492, Expect=2e-161]} {RNA1509_42629} {RNA1310_4660} {RNA815_14049} Mlig455_067604 {REF} {Length: 2698} {Pfam: Calx-beta domain [PF03160.16, score=145.3]; Sodium/calcium exchanger protein [PF01699.26, score=82.2]; C-terminal extension of sodium/calcium exchanger domain [PF16494.7, score=22.7]; Domain of unknown function (DUF4843) [PF16132.7, score=19.8]} {Human: ENSG00000183023, SLC8A1, solute carrier family 8 member A1, [Score=337, Expect=5e-104]; ENSG00000100678, SLC8A3, solute carrier family 8 member A3, [Score=327, Expect=2e-100]} {Mouse: ENSMUSG00000079055, Slc8a3, solute carrier family 8 (sodium/calcium exchanger), member 3, [Score=330, Expect=7e-102]; ENSMUSG00000054640, Slc8a1, solute carrier family 8 (sodium/calcium exchanger), member 1, [Score=328, Expect=8e-101]} {Dmel: FBgn0013995, Calx, Na/Ca-exchange protein, [Score=338, Expect=1e-104]} {Celegans: WBGene00003568, ncx-3, Na/Ca eXchangers, [Score=346, Expect=6e-109]} {Smed: dd_Smed_v6_7229_0_1, dd_Smed_v6_7229_0_1, [Score=321, Expect=2e-99]} {RNA1509_42629} {RNA1310_4546.1} {RNA815_14049} |
| 19. | MligTC455_43326 | 39 | 0.8 | Mlig455_057987 | Neo: - Age: - |
1.851 | - | - | - | 0.877 | 0.974 | - | Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308} | |
| 20. | MligTC455_14043 | 12 | 0.26 | Mlig455_016776 | Neo: - Age: - |
ANKRD63 | 1.849 | - | - | - | 0.852 | 0.997 | - | Mlig455_016776 {REF} {Length: 1715} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=122.1]; Ankyrin repeats (many copies) [PF13637.8, score=70.6]; Ankyrin repeats (many copies) [PF13857.8, score=54.8]; Ankyrin repeat [PF00023.32, score=50.2]; Ankyrin repeat [PF13606.8, score=43.7]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=130, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=131, Expect=9e-34]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=66.2, Expect=3e-11]} {Celegans: WBGene00012124, T28D6.4, [Score=62.8, Expect=3e-10]} {Smed: dd_Smed_v6_11187_0_3, dd_Smed_v6_11187_0_3, [Score=56.6, Expect=2e-08]} {RNA815_38023} |
| 21. | MligTC455_14675 | 24 | 0.5 | Mlig455_009944 | Neo: - Age: logFC(26M/2M)=-0.658 |
KCNIP2 | 1.843 | - | - | - | 0.857 | 0.986 | - | Mlig455_009944 {REF} {Length: 1579} {Pfam: EF-hand domain pair [PF13499.8, score=20.2]; EF hand [PF00036.34, score=18.7]} {Human: ENSG00000120049, KCNIP2, potassium voltage-gated channel interacting protein 2, [Score=159, Expect=3e-47]; ENSG00000182132, KCNIP1, potassium voltage-gated channel interacting protein 1, [Score=158, Expect=9e-47]; ENSG00000185774, KCNIP4, potassium voltage-gated channel interacting protein 4, [Score=158, Expect=2e-46]; ENSG00000115041, KCNIP3, potassium voltage-gated channel interacting protein 3, [Score=156, Expect=6e-46]} {Mouse: ENSMUSG00000025221, Kcnip2, Kv channel-interacting protein 2, [Score=160, Expect=1e-47]; ENSMUSG00000029088, Kcnip4, Kv channel interacting protein 4, [Score=158, Expect=2e-46]; ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=157, Expect=2e-46]; ENSMUSG00000079056, Kcnip3, Kv channel interacting protein 3, calsenilin, [Score=153, Expect=6e-45]} {Dmel: FBgn0265595, CG44422, [Score=139, Expect=1e-37]} {Celegans: WBGene00003563, ncs-1, Neuronal calcium sensor 1, [Score=112, Expect=7e-30]} {Smed: dd_Smed_v6_9434_0_1, dd_Smed_v6_9434_0_1, [Score=127, Expect=1e-35]} {RNA1310_70865} {RNA815_28132} |
| 22. | MligTC455_21801 | 58 | 1.22 | Mlig455_015442, Mlig455_032138 | Neo: - Age: - |
NPY1R | 1.843 | - | - | 0.850 | - | 0.993 | - | Mlig455_015442 {REF} {Length: 2461} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=130.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=26.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.9]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=128, Expect=5e-32]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=2e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=140, Expect=4e-36]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=120, Expect=1e-29]} {Smed: dd_Smed_v6_25204_0_1, dd_Smed_v6_25204_0_1, [Score=208, Expect=2e-61]} {RNA1310_49156} {RNA815_43783} Mlig455_032138 {REF} {Length: 2633} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=129.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.6]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=126, Expect=2e-31]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=4e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=136, Expect=1e-34]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_25934_0_1, dd_Smed_v6_25934_0_1, [Score=207, Expect=5e-61]} {RNA1310_49156} {RNA815_43783} |
| 23. | MligTC455_24952 | 637 | 13.28 | Mlig455_054178, Mlig455_060727 | Neo: - Age: Down-Up-Down Region-specific R2: 4.165 Region-enriched R2: 3.160/0.00003 Regeneration-downregulated BL: -4.774 Regeneration-depleted BL: -4.774 |
CCDC169 | 1.835 | - | - | - | 0.859 | 0.976 | - | Mlig455_054178 {REF} {Length: 1390} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} Mlig455_060727 {REF} {Length: 1391} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029, RNA1509_8270} {RNA1509_8270, RNA815_11545} |
| 24. | MligTC455_49557 | 280 | 5.82 | Mlig455_017273 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.728 Region-specific R2: 3.642 Region-enriched R2: 3.187/0.00196 |
1.828 | - | - | - | 0.836 | 0.992 | - | Mlig455_017273 {REF} {Length: 1333} {RNA1509_52848} {RNA1310_64923, RNA1509_52848} {RNA1509_52848, RNA815_51063} | |
| 25. | MligTC455_47590 | 22 | 0.46 | Mlig455_017675, Mlig455_053765 | Neo: - Age: - |
LRRC74A | 1.825 | - | - | 0.875 | - | 0.950 | - | Mlig455_017675 {REF} {Length: 3797} {Pfam: Leucine Rich repeat [PF13516.8, score=47.9]; EF-hand domain pair [PF13499.8, score=29.1]; EF-hand domain [PF13405.8, score=28.8]; EF hand [PF00036.34, score=28.6]; EF-hand domain pair [PF13833.8, score=18.6]} {Human: ENSG00000100565, LRRC74A, leucine rich repeat containing 74A, [Score=143, Expect=3e-36]} {Mouse: ENSMUSG00000059114, Lrrc74a, leucine rich repeat containing 74A, [Score=142, Expect=5e-36]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [Score=50.4, Expect=5e-07]} {Smed: dd_Smed_v6_14506_0_1, dd_Smed_v6_14506_0_1, [Score=169, Expect=4e-45]} {RNA1310_50089} Mlig455_053765 {REF} {Length: 3797} {Pfam: Leucine Rich repeat [PF13516.8, score=47.9]; EF-hand domain pair [PF13499.8, score=29.1]; EF-hand domain [PF13405.8, score=28.8]; EF hand [PF00036.34, score=28.6]; EF-hand domain pair [PF13833.8, score=18.6]} {Human: ENSG00000100565, LRRC74A, leucine rich repeat containing 74A, [Score=143, Expect=3e-36]} {Mouse: ENSMUSG00000059114, Lrrc74a, leucine rich repeat containing 74A, [Score=142, Expect=5e-36]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [Score=50.4, Expect=5e-07]} {Smed: dd_Smed_v6_14506_0_1, dd_Smed_v6_14506_0_1, [Score=169, Expect=4e-45]} {RNA1310_50089} |
| 26. | MligTC455_26091 | 161 | 3.36 | Mlig455_047190 | Neo: - Age: - Region-enriched R2: 4.521/0.00020 |
1.819 | - | - | - | 0.842 | 0.977 | - | Mlig455_047190 {REF} {Length: 2450} {Pfam: Lectin C-type domain [PF00059.23, score=23.6]} {RNA1509_2912} {RNA1310_27113} {RNA815_24719} | |
| 27. | MligTC455_49774 | 201 | 4.18 | Mlig455_028574 | Neo: - Age: - Region-enriched R4: 12.872/0.00005 Regeneration-upregulated R3: 5.313 Regeneration-enriched R3: 5.313 |
1.819 | - | - | - | 0.821 | 0.998 | - | Mlig455_028574 {REF} {Length: 1498} {Pfam: Lectin C-type domain [PF00059.23, score=35.8]} {RNA1509_20946} {RNA1310_44606} {RNA815_35640} | |
| 28. | MligTC455_17609 | 87 | 1.82 | Mlig455_059630, Mlig455_059644 | Neo: - Age: Up-Down-Down |
GALR2 | 1.797 | - | - | - | 0.804 | 0.993 | - | Mlig455_059630 {REF} {Length: 3780} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=154.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=38.7]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=27.6]; Serpentine type 7TM GPCR chemoreceptor Sru [PF10322.11, score=19.7]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=145, Expect=5e-39]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=134, Expect=6e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=111, Expect=2e-26]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=102, Expect=2e-23]} {Smed: dd_Smed_v6_15151_0_1, dd_Smed_v6_15151_0_1, [RH, Score=241, Expect=4e-75]} {RNA1310_55640} {RNA815_36728} Mlig455_059644 {REF} {Length: 3887} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=154.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=38.7]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=27.6]; Serpentine type 7TM GPCR chemoreceptor Sru [PF10322.11, score=19.7]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=145, Expect=5e-39]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=134, Expect=6e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=111, Expect=2e-26]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=102, Expect=2e-23]} {Smed: dd_Smed_v6_15151_0_1, dd_Smed_v6_15151_0_1, [RH, Score=241, Expect=4e-75]} {RNA1310_55640} {RNA815_36728} |
| 29. | MligTC455_17664 | 159 | 3.32 | Mlig455_006486, Mlig455_006606 | Neo: - |
PLCB1 | 1.786 | - | - | 0.815 | - | 0.971 | - | Mlig455_006486 {REF} {Length: 4855} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=200.4]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=125.9]; PH domain [PF17787.3, score=104.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=34.0]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=808, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=805, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=811, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=784, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [RH, Score=438, Expect=3e-131]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=639, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=692, Expect=0.0]} {RNA1509_53425} {RNA1310_39849} {RNA815_30464} Mlig455_006606 {REF} {Length: 4322} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=199.3]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=126.1]; PH domain [PF17787.3, score=117.1]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=33.9]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=840, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=825, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=843, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=814, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [RH, Score=451, Expect=2e-136]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=663, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_2, dd_Smed_v6_3221_0_2, [Score=701, Expect=0.0]} {RNA1509_53425} {RNA1310_39849, RNA1509_53425} {RNA1509_53425, RNA815_30464} |
| 30. | MligTC455_25106 | 38 | 0.79 | Mlig455_001755, Mlig455_001778 | Neo: - Age: - Region-enriched R2: 9.161/0.00275 |
AGTR2, NPFFR2 | 1.773 | - | - | - | 0.806 | 0.967 | - | Mlig455_001755 {REF} {Length: 2284} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=30.7]} {Human: ENSG00000180772, AGTR2, angiotensin II receptor type 2, [Score=57.4, Expect=2e-09]} {Mouse: ENSMUSG00000031210, Gpr165, G protein-coupled receptor 165, [Score=58.9, Expect=5e-10]; ENSMUSG00000068122, Agtr2, angiotensin II receptor, type 2, [Score=58.2, Expect=8e-10]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=60.8, Expect=1e-10]} {Celegans: WBGene00006576, tkr-1, Probable G-protein coupled receptor tkr-1, [Score=48.9, Expect=6e-07]} {Smed: dd_Smed_v6_29182_0_1, dd_Smed_v6_29182_0_1, [Score=86.7, Expect=3e-20]} {RNA1310_104492} {RNA815_26451} Mlig455_001778 {REF} {Length: 2260} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=174.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=50.4]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=139, Expect=1e-35]; ENSG00000137252, HCRTR2, hypocretin receptor 2, [Score=139, Expect=5e-36]} {Mouse: ENSMUSG00000028778, Hcrtr1, hypocretin (orexin) receptor 1, [Score=145, Expect=5e-39]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=142, Expect=6e-38]; ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=139, Expect=3e-36]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=181, Expect=6e-50]} {Celegans: WBGene00016842, npr-35, NeuroPeptide Receptor family, [RH, Score=127, Expect=6e-33]} {Smed: dd_Smed_v6_29182_0_1, dd_Smed_v6_29182_0_1, [RH, Score=235, Expect=8e-74]} {RNA1310_139909} {RNA815_26451} |
| 31. | MligTC455_44845 | 96 | 2 | Mlig455_063520 | Neo: - Age: - |
LHX5 | 1.767 | - | - | - | 0.809 | 0.958 | - | Mlig455_063520 {REF} {Length: 4042} {Pfam: LIM domain [PF00412.24, score=116.9]; Homeodomain [PF00046.31, score=69.5]; Homeobox KN domain [PF05920.13, score=24.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=19.8]} {Human: ENSG00000089116, LHX5, LIM homeobox 5, [Score=208, Expect=9e-59]; ENSG00000273706, LHX1, LIM homeobox 1, [Score=199, Expect=1e-55]; ENSG00000274577, LHX1, LIM homeobox 1, [Score=199, Expect=1e-55]} {Mouse: ENSMUSG00000029595, Lhx5, LIM homeobox protein 5, [Score=207, Expect=1e-58]; ENSMUSG00000018698, Lhx1, LIM homeobox protein 1, [Score=199, Expect=1e-55]} {Dmel: FBgn0026411, Lim1, LIM homeobox 1, [Score=191, Expect=3e-52]} {Celegans: WBGene00003000, lin-11, [Score=141, Expect=6e-36]} {Smed: dd_Smed_v6_11521_0_1, dd_Smed_v6_11521_0_1, [RH, Score=185, Expect=5e-49]} {RNA1509_55597} {RNA1310_42478} {RNA815_25756} |
| 32. | MligTC455_43664 | 35 | 0.73 | Mlig455_039606 | Neo: - Age: - Region-enriched R4: 6.555/0.01908 |
KY | 1.766 | - | - | - | 0.791 | 0.975 | - | Mlig455_039606 {REF} {Length: 4549} {Pfam: WD domain, G-beta repeat [PF00400.34, score=37.6]} {Human: ENSG00000174611, KY, kyphoscoliosis peptidase, [Score=113, Expect=4e-25]} {Mouse: ENSMUSG00000035606, Ky, kyphoscoliosis peptidase, [Score=112, Expect=7e-25]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=147, Expect=8e-36]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=142, Expect=1e-35]} {Smed: dd_Smed_v6_8615_0_1, dd_Smed_v6_8615_0_1, [Score=293, Expect=7e-90]} {RNA1509_7582} {RNA1310_2203} {RNA815_6135} |
| 33. | MligTC455_41250 | 104 | 2.16 | Mlig455_010456, Mlig455_010476, Mlig455_061901 | Neo: - Age: - |
1.765 | - | - | 0.801 | - | 0.964 | - | Mlig455_010456 {REF} {Length: 2561} {RNA1310_39237} {RNA815_40339} Mlig455_010476 {REF} {Length: 2776} {RNA1310_39237} {RNA815_40339} Mlig455_061901 {REF} {Length: 2797} {RNA1310_39237} {RNA815_40339} |
|
| 34. | MligTC455_48127 | 47 | 0.97 | Mlig455_037173 | Neo: - Age: - |
1.764 | - | - | - | 0.773 | 0.991 | - | Mlig455_037173 {REF} {Length: 1938} {RNA1310_42908} {RNA815_22744} | |
| 35. | MligTC455_51238 | 58 | 1.21 | Mlig455_011511 | Neo: - Age: - |
KCNMA1 | 1.761 | - | - | - | 0.779 | 0.982 | - | Mlig455_011511 {REF} {Length: 2300} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=100.8]; Ion channel [PF07885.18, score=29.2]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=272, Expect=4e-80]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=271, Expect=4e-79]} {Dmel: FBgn0003429, slo, slowpoke, [Score=180, Expect=8e-48]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=269, Expect=9e-79]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=294, Expect=9e-88]} {RNA1310_5274} {RNA815_44227} |
| 36. | MligTC455_45621 | 610 | 12.72 | Mlig455_041531 | Neo: - Age: - Region-specific R2: 5.645 Region-enriched R2: 4.169/0.00001 |
1.758 | - | - | - | 0.773 | 0.985 | - | Mlig455_041531 {REF} {Length: 1004} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982, RNA1509_8166} {RNA1310_46295, RNA1509_31982, RNA1509_8166} {RNA1509_31982, RNA1509_8166, RNA815_23543} | |
| 37. | MligTC455_09557 | 33 | 0.68 | Mlig455_059478 | Neo: - Age: Up-Down-Down |
B3GNT4 | 1.756 | - | - | 0.785 | - | 0.971 | - | Mlig455_059478 {REF} {Length: 2800} {Pfam: Galactosyltransferase [PF01762.23, score=72.9]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=75.9, Expect=2e-14]} {Mouse: ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=73.6, Expect=1e-13]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=110, Expect=5e-27]} {RNA1310_43488} |
| 38. | MligTC455_32502 | 47 | 0.98 | Mlig455_065385 | Neo: - Age: - |
GRIA1 | 1.753 | - | - | - | 0.770 | 0.983 | - | Mlig455_065385 {REF} {Length: 4211} {Pfam: Ligand-gated ion channel [PF00060.28, score=197.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=125.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=87.6]; Receptor family ligand binding region [PF01094.30, score=62.0]} {Human: ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [RH, Score=590, Expect=0.0]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [RH, Score=566, Expect=0.0]} {Mouse: ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [RH, Score=590, Expect=0.0]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [RH, Score=564, Expect=0.0]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [RH, Score=561, Expect=0.0]} {Dmel: FBgn0038837, CG3822, [Score=479, Expect=2e-155]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [RH, Score=484, Expect=3e-156]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [RH, Score=707, Expect=0.0]} {RNA1509_47919} {RNA1310_3776} {RNA815_11355.1} |
| 39. | MligTC455_38565 | 45 | 0.93 | Mlig455_054917 | Neo: - Age: - |
PCDH11X | 1.747 | - | - | 0.761 | - | 0.986 | - | Mlig455_054917 {REF} {Length: 4432} {Pfam: Cadherin domain [PF00028.19, score=225.5]; Cadherin-like [PF08266.14, score=38.0]} {Human: ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=237, Expect=4e-63]; ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=236, Expect=3e-63]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=238, Expect=6e-64]; ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=231, Expect=6e-62]; ENSMUSG00000044043, Pcdhb14, protocadherin beta 14, [Score=228, Expect=1e-61]; ENSMUSG00000045876, Pcdhb8, protocadherin beta 8, [Score=227, Expect=1e-61]} {Dmel: FBgn0284247, ds, dachsous, [Score=211, Expect=1e-54]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=168, Expect=9e-42]} {Smed: dd_Smed_v6_7973_0_2, dd_Smed_v6_7973_0_2, [Score=267, Expect=1e-73]} {RNA1310_85042} |
| 40. | MligTC455_46725 | 1277 | 26.6 | Mlig455_002797, Mlig455_002811 | Neo: - Age: - Region-enriched R7: 2.089/0.02985 |
TMPRSS4 | 1.747 | - | - | 0.755 | - | 0.992 | - | Mlig455_002797 {REF} {Length: 1278} {Pfam: Trypsin [PF00089.28, score=217.0]; Trypsin-like peptidase domain [PF13365.8, score=29.1]} {Human: ENSG00000137648, TMPRSS4, transmembrane serine protease 4, [RH, Score=177, Expect=8e-53]} {Mouse: ENSMUSG00000032091, Tmprss4, transmembrane protease, serine 4, [RH, Score=171, Expect=5e-49]} {Dmel: FBgn0035501, CG1299, [RH, Score=160, Expect=2e-44]} {Celegans: WBGene00006619, try-1, TRYpsin-like protease, [Score=127, Expect=3e-34]} {Smed: dd_Smed_v6_2492_0_1, dd_Smed_v6_2492_0_1, [RH, Score=283, Expect=4e-94]} {RNA1509_14801} {RNA1310_24334.1} {RNA815_10378} Mlig455_002811 {REF} {Length: 1406} {Pfam: Trypsin [PF00089.28, score=216.7]; Trypsin-like peptidase domain [PF13365.8, score=29.0]} {Human: ENSG00000137648, TMPRSS4, transmembrane serine protease 4, [RH, Score=176, Expect=1e-52]} {Mouse: ENSMUSG00000032091, Tmprss4, transmembrane protease, serine 4, [RH, Score=171, Expect=3e-49]; ENSMUSG00000033825, Tpsb2, tryptase beta 2, [RH, Score=163, Expect=9e-48]} {Dmel: FBgn0035501, CG1299, [RH, Score=160, Expect=2e-44]} {Celegans: WBGene00006619, try-1, TRYpsin-like protease, [Score=127, Expect=3e-34]} {Smed: dd_Smed_v6_2492_0_1, dd_Smed_v6_2492_0_1, [RH, Score=285, Expect=7e-95]} {RNA1509_14801} {RNA1310_24334.1, RNA1509_14801} {RNA1509_14801, RNA815_10378} |
| 41. | MligTC455_51101 | 25 | 0.51 | Mlig455_015276 | Neo: - Age: - Region-enriched R4: 3.968/0.02941 |
CALM2 | 1.747 | - | - | 0.778 | - | 0.969 | - | Mlig455_015276 {REF} {Length: 810} {Pfam: EF hand [PF00036.34, score=113.6]; EF-hand domain pair [PF13499.8, score=105.2]; EF-hand domain [PF13405.8, score=85.5]; EF-hand domain pair [PF13833.8, score=81.8]; EF hand [PF13202.8, score=77.7]; EF-hand domain [PF14658.8, score=48.9]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.2]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; Dockerin type I domain [PF00404.20, score=23.9]; Uncharacterised protein family (UPF0154) [PF03672.15, score=22.9]; SurA N-terminal domain [PF13623.8, score=18.8]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=169, Expect=2e-53]; ENSG00000198668, CALM1, calmodulin 1, [Score=167, Expect=4e-53]; ENSG00000160014, CALM3, calmodulin 3, [Score=167, Expect=4e-53]; ENSG00000178363, CALML3, calmodulin like 3, [Score=162, Expect=2e-51]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=167, Expect=2e-53]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=167, Expect=2e-53]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=167, Expect=2e-53]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=163, Expect=9e-52]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=167, Expect=1e-53]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=167, Expect=2e-53]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=167, Expect=1e-53]} {RNA1310_38833} {RNA815_22576} |
| 42. | MligTC455_24985 | 43 | 0.89 | Mlig455_005348, Mlig455_005464 | Neo: - Age: - |
ADRA1A, HTR1A | 1.742 | - | - | 0.768 | - | 0.974 | - | Mlig455_005348 {REF} {Length: 1845} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=222.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=41.4]} {Human: ENSG00000120907, ADRA1A, adrenoceptor alpha 1A, [Score=186, Expect=3e-54]; ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=184, Expect=1e-53]; ENSG00000170214, ADRA1B, adrenoceptor alpha 1B, [Score=179, Expect=1e-50]} {Mouse: ENSMUSG00000045875, Adra1a, adrenergic receptor, alpha 1a, [Score=181, Expect=1e-52]; ENSMUSG00000021721, Htr1a, 5-hydroxytryptamine (serotonin) receptor 1A, [Score=179, Expect=5e-52]; ENSMUSG00000050541, Adra1b, adrenergic receptor, alpha 1b, [Score=179, Expect=7e-51]} {Dmel: FBgn0011582, Dop1R1, Dopamine 1-like receptor 1, [Score=162, Expect=3e-45]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=181, Expect=7e-53]} {Smed: dd_Smed_v6_33950_0_1, dd_Smed_v6_33950_0_1, [Score=254, Expect=1e-80]} {RNA1310_56787} Mlig455_005464 {REF} {Length: 1742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=223.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.7]; Presenilin [PF01080.19, score=17.5]} {Human: ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=194, Expect=7e-57]; ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=191, Expect=4e-55]} {Mouse: ENSMUSG00000058620, Adra2b, adrenergic receptor, alpha 2b, [RH, Score=184, Expect=5e-53]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=172, Expect=1e-46]} {Celegans: WBGene00017157, tyra-2, Tyramine receptor tyra-2, [RH, Score=216, Expect=3e-65]} {Smed: dd_Smed_v6_33950_0_1, dd_Smed_v6_33950_0_1, [RH, Score=329, Expect=1e-108]} {RNA1310_56787} |
| 43. | MligTC455_46885 | 72 | 1.49 | Mlig455_015138 | Neo: - Age: - |
PRKG2 | 1.739 | - | - | - | 0.746 | 0.993 | - | Mlig455_015138 {REF} {Length: 3064} {Pfam: Protein kinase domain [PF00069.27, score=227.4]; Cyclic nucleotide-binding domain [PF00027.31, score=128.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=118.5]; Kinase-like [PF14531.8, score=25.1]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=674, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=674, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=682, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=668, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=676, Expect=0.0]} {RNA1509_26653} {RNA1310_15330.1} {RNA815_26005} |
| 44. | MligTC455_48128 | 18 | 0.37 | Mlig455_052326 | Neo: - Age: - |
1.739 | - | - | - | 0.742 | 0.997 | - | Mlig455_052326 {REF} {Length: 3582} {RNA1310_42908} {RNA815_22744} | |
| 45. | MligTC455_12514 | 30 | 0.63 | Mlig455_037415 | Neo: - Age: - |
CHRNA6 | 1.731 | - | - | 0.767 | - | 0.964 | - | Mlig455_037415 {REF} {Length: 1606} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=77.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=77.4, Expect=4e-16]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=75.1, Expect=2e-15]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=73.9, Expect=7e-15]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=80.5, Expect=3e-17]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=84.7, Expect=7e-19]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=72.8, Expect=5e-15]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=82.0, Expect=3e-18]} {RNA1509_53098} {RNA1310_110770} {RNA815_49679} |
| 46. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
1.731 | - | - | - | 0.757 | 0.974 | - | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
| 47. | MligTC455_53188 | 211 | 4.39 | Mlig455_029600 | Neo: - Age: Down-Up-Up |
1.73 | - | - | 0.769 | - | 0.961 | - | Mlig455_029600 {REF} {Length: 1979} {Pfam: Globin [PF00042.24, score=38.2]} {RNA1509_38771} {RNA1310_34513} {RNA815_16338} | |
| 48. | MligTC455_17089 | 173 | 3.6 | Mlig455_022974 | Neo: - Age: - Region-enriched R4: 2.568/0.01700 |
1.729 | - | - | - | 0.765 | 0.964 | - | Mlig455_022974 {REF} {Length: 1697} {RNA1509_56619} {RNA1310_21133.1} {RNA815_8631.1} | |
| 49. | MligTC455_20114 | 4655 | 96.97 | Mlig455_032750 | Neo: - Age: - Region-enriched R2: 6.812/0.00000 |
ADAMTS7 | 1.729 | - | - | 0.746 | - | 0.983 | - | Mlig455_032750 {REF} {Length: 1794} {Pfam: Metallo-peptidase family M12 [PF13688.8, score=51.5]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=44.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=39.8]; Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=37.0]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=26.8]; ADAM cysteine-rich domain [PF17771.3, score=26.3]; Astacin (Peptidase family M12A) [PF01400.26, score=18.3]} {Human: ENSG00000136378, ADAMTS7, ADAM metallopeptidase with thrombospondin type 1 motif 7, [Score=72.4, Expect=1e-12]; ENSG00000134917, ADAMTS8, ADAM metallopeptidase with thrombospondin type 1 motif 8, [Score=72.0, Expect=1e-12]} {Mouse: ENSMUSG00000058145, Adamts17, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17, [Score=70.5, Expect=3e-12]; ENSMUSG00000031994, Adamts8, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 8, [Score=70.1, Expect=3e-12]; ENSMUSG00000046169, Adamts6, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 6, [Score=69.7, Expect=4e-12]; ENSMUSG00000049538, Adamts16, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16, [Score=68.2, Expect=1e-11]; ENSMUSG00000006403, Adamts4, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4, [Score=67.4, Expect=2e-11]} {Dmel: FBgn0029791, CG4096, [Score=74.3, Expect=1e-13]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [Score=58.5, Expect=6e-09]} {RNA1509_811} {RNA1310_18102.1, RNA1509_811} {RNA1509_811, RNA815_7066} |
| 50. | MligTC455_13094 | 121 | 2.52 | Mlig455_005442, Mlig455_005513 | Neo: - Age: Up-Up-Down |
1.728 | - | - | - | 0.765 | 0.963 | - | Mlig455_005442 {REF} {Length: 3816} {Smed: dd_Smed_v6_15433_0_1, dd_Smed_v6_15433_0_1, [Score=141, Expect=1e-34]} {RNA1509_41201} {RNA1310_51044} {RNA815_32534} Mlig455_005513 {REF} {Length: 685} {NoTransDecoderORF} {RNA1310_56412} {RNA815_32534} |
|
| 51. | MligTC455_20113 | 4626 | 96.37 | Mlig455_032728 | Neo: - Age: - Region-enriched R2: 7.104/0.00000 |
ADAMTS4 | 1.728 | - | - | 0.745 | - | 0.983 | - | Mlig455_032728 {REF} {Length: 1834} {Pfam: Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=34.1]; Metallo-peptidase family M12 [PF13688.8, score=30.1]} {Human: ENSG00000158859, ADAMTS4, ADAM metallopeptidase with thrombospondin type 1 motif 4, [Score=50.1, Expect=3e-06]; ENSG00000154734, ADAMTS1, ADAM metallopeptidase with thrombospondin type 1 motif 1, [Score=48.1, Expect=3e-06]} {Mouse: ENSMUSG00000006403, Adamts4, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4, [Score=50.1, Expect=2e-06]} {RNA1509_811} {RNA1310_18102.1} {RNA815_7066} |
| 52. | MligTC455_43557 | 362 | 7.55 | Mlig455_059172, Mlig455_065527 | Neo: - Age: Down-Down-Up Region-specific R2: 6.284 Region-enriched R2: 5.832/0.00001 |
ANKRD63 | 1.728 | - | - | - | 0.764 | 0.964 | - | Mlig455_059172 {REF} {Length: 1739} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.2]; Ankyrin repeats (many copies) [PF13637.8, score=42.6]; Ankyrin repeat [PF13606.8, score=27.6]; Ankyrin repeats (many copies) [PF13857.8, score=27.1]; Ankyrin repeat [PF00023.32, score=25.9]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=67.4, Expect=7e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=49.3, Expect=7e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=49.3, Expect=4e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_44826} {RNA815_62096} Mlig455_065527 {REF} {Length: 2998} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=52.3]; Ankyrin repeats (many copies) [PF13637.8, score=42.0]; Ankyrin repeats (many copies) [PF13857.8, score=26.7]; Ankyrin repeat [PF00023.32, score=26.0]; Ankyrin repeat [PF13606.8, score=22.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=68.2, Expect=6e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=50.1, Expect=5e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=50.4, Expect=2e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=80.9, Expect=2e-16]} {RNA1509_30872} {RNA1310_44826} {RNA815_62096} |
| 53. | MligTC455_50435 | 8697 | 181.19 | Mlig455_039060 | Neo: - Age: logFC(26M/2M)=3.232 Region-enriched R2: 1.067/0.02505 Regeneration-downregulated BL: -1.692 Regeneration-depleted BL: -1.692 |
1.724 | - | - | - | 0.749 | 0.975 | - | Mlig455_039060 {REF} {Length: 1433} {Pfam: Thiazole biosynthesis protein ThiG [PF05690.16, score=31.0]; SOR/SNZ family [PF01680.19, score=29.1]; Histidine biosynthesis protein [PF00977.23, score=21.2]} {Smed: dd_Smed_v6_1240_0_1, dd_Smed_v6_1240_0_1, [Score=162, Expect=2e-50]} {RNA1509_1321} {RNA1310_25568} {RNA815_8446.1} | |
| 54. | MligTC455_50436 | 8699 | 181.24 | Mlig455_039065 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=-0.358 Region-enriched R2: 1.068/0.02488 Regeneration-downregulated BL: -1.693 Regeneration-depleted BL: -1.693 |
1.724 | - | - | - | 0.749 | 0.975 | - | Mlig455_039065 {REF} {Length: 1569} {Pfam: SOR/SNZ family [PF01680.19, score=359.9]; Thiazole biosynthesis protein ThiG [PF05690.16, score=37.0]; Histidine biosynthesis protein [PF00977.23, score=21.5]; Dihydrouridine synthase (Dus) [PF01207.19, score=19.8]; Indole-3-glycerol phosphate synthase [PF00218.23, score=19.4]} {Smed: dd_Smed_v6_1240_0_1, dd_Smed_v6_1240_0_1, [RH, Score=441, Expect=1e-157]} {RNA1509_1321, RNA1509_4701} {RNA1310_25568, RNA1509_4701} {RNA1509_4701, RNA815_8446.1} | |
| 55. | MligTC455_24951 | 220 | 4.58 | Mlig455_052169 | Neo: - Age: - Region-specific R2: 4.554 Region-enriched R2: 4.264/0.00008 Regeneration-downregulated R2: -1.743 Regeneration-depleted R2: -1.743 |
CCDC169 | 1.722 | - | - | - | 0.763 | 0.959 | - | Mlig455_052169 {REF} {Length: 1369} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} |
| 56. | MligTC455_14149 | 226 | 4.71 | Mlig455_017664, Mlig455_017690, Mlig455_017741 | Neo: - Age: Up-Down-Down |
SLC6A5 | 1.719 | - | - | - | 0.722 | 0.997 | - | Mlig455_017664 {REF} {Length: 2439} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=584.2]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=510, Expect=5e-171]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=509, Expect=7e-171]} {Dmel: FBgn0034911, CG5549, [Score=509, Expect=3e-166]} {Celegans: WBGene00004902, snf-3, Sodium- and chloride-dependent betaine transporter, [Score=373, Expect=1e-120]} {Smed: dd_Smed_v6_10458_0_2, dd_Smed_v6_10458_0_2, [Score=500, Expect=2e-169]} {RNA1509_52349} {RNA1310_8571.2} {RNA815_10787} Mlig455_017690 {REF} {Length: 2567} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=581.8]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=513, Expect=4e-172]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=512, Expect=8e-172]} {Dmel: FBgn0034911, CG5549, [Score=520, Expect=2e-170]} {Celegans: WBGene00004902, snf-3, Sodium- and chloride-dependent betaine transporter, [Score=371, Expect=5e-120]} {Smed: dd_Smed_v6_10458_0_1, dd_Smed_v6_10458_0_1, [Score=502, Expect=1e-169]} {RNA1509_52349} {RNA1310_8571.1, RNA1509_52349} {RNA1509_52349, RNA815_10787} Mlig455_017741 {REF} {Length: 2497} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=582.2]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=518, Expect=1e-173]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=516, Expect=3e-173]} {Dmel: FBgn0034911, CG5549, [Score=519, Expect=8e-170]} {Celegans: WBGene00004902, snf-3, Sodium- and chloride-dependent betaine transporter, [Score=371, Expect=1e-119]} {Smed: dd_Smed_v6_10458_0_1, dd_Smed_v6_10458_0_1, [Score=511, Expect=8e-173]} {RNA1509_52349} {RNA1310_8571.1} {RNA815_10787} |
| 57. | MligTC455_14829 | 56 | 1.17 | Mlig455_053237 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=1.599 Region-enriched R2: 3.828/0.03404 |
SSUH2 | 1.718 | - | - | - | 0.758 | 0.960 | - | Mlig455_053237 {REF} {Length: 1420} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=156, Expect=2e-43]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=117, Expect=2e-29]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=87.4, Expect=9e-19]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
| 58. | MligTC455_15837 | 58 | 1.21 | Mlig455_058574 | Neo: - Age: Up-Down-Up |
PLEKHG5 | 1.718 | - | - | - | 0.753 | 0.965 | - | Mlig455_058574 {REF} {Length: 3473} {Pfam: RhoGEF domain [PF00621.22, score=89.0]; Pleckstrin homology domain [PF15405.8, score=20.1]} {Human: ENSG00000171680, PLEKHG5, pleckstrin homology and RhoGEF domain containing G5, [Score=191, Expect=1e-49]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=194, Expect=1e-50]} {Dmel: FBgn0261556, CG42674, [Score=147, Expect=1e-35]} {Celegans: WBGene00006476, rhgf-2, RHGF-2; RHo Guanine nucleotide exchange Factor, [RH, Score=142, Expect=3e-34]} {Smed: dd_Smed_v6_10072_0_1, dd_Smed_v6_10072_0_1, [Score=171, Expect=2e-44]} {RNA1310_47096} {RNA815_12538} |
| 59. | MligTC455_41512 | 268 | 5.59 | Mlig455_057018 | Neo: - Age: Down-Down-Up |
HMCN2 | 1.718 | - | - | 0.758 | - | 0.960 | - | Mlig455_057018 {REF} {Length: 2115} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=167.2]; Immunoglobulin domain [PF13927.8, score=124.8]; Immunoglobulin domain [PF13895.8, score=78.7]; Immunoglobulin domain [PF00047.27, score=77.2]; Immunoglobulin V-set domain [PF07686.19, score=45.1]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=40.4]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=83.6, Expect=3e-16]; ENSG00000138347, MYPN, myopalladin, [Score=82.8, Expect=4e-16]; ENSG00000129116, PALLD, palladin, cytoskeletal associated protein, [Score=82.4, Expect=4e-16]; ENSG00000072195, SPEG, SPEG complex locus, [Score=82.0, Expect=6e-16]} {Mouse: ENSMUSG00000061462, Obscn, obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF, [Score=84.7, Expect=8e-17]; ENSMUSG00000058056, Palld, palladin, cytoskeletal associated protein, [Score=81.6, Expect=4e-16]; ENSMUSG00000026207, Speg, SPEG complex locus, [Score=80.9, Expect=9e-16]} {Dmel: FBgn0052311, zormin, [Score=102, Expect=7e-23]} {Celegans: WBGene00006820, unc-89, Muscle M-line assembly protein unc-89, [Score=77.4, Expect=8e-15]} {Smed: dd_Smed_v6_13910_0_1, dd_Smed_v6_13910_0_1, [Score=127, Expect=3e-31]} {RNA1509_44395} {RNA1310_15128.1, RNA1509_44395} {RNA1509_44395, RNA815_29263} |
| 60. | MligTC455_41011 | 90 | 1.87 | Mlig455_014030, Mlig455_014036 | Neo: - Age: Down-Up-Down |
1.716 | - | - | 0.717 | - | 0.999 | - | Mlig455_014030 {REF} {Length: 1659} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=41.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=36.2]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=95.1, Expect=2e-21]} {RNA1310_70554} {RNA815_47734} Mlig455_014036 {REF} {Length: 1980} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=51.3]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.7]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=104, Expect=3e-24]} {RNA1310_70554} {RNA815_47734} |
|
| 61. | MligTC455_21638 | 50 | 1.05 | Mlig455_026393 | Neo: - Age: Down-Up-Down |
SLC6A5 | 1.714 | - | - | - | 0.764 | 0.950 | - | Mlig455_026393 {REF} {Length: 1896} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=352.8]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=310, Expect=2e-97]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=309, Expect=3e-97]} {Dmel: FBgn0034911, CG5549, [Score=310, Expect=6e-95]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=226, Expect=2e-67]} {Smed: dd_Smed_v6_10458_0_1, dd_Smed_v6_10458_0_1, [Score=276, Expect=1e-85]} {RNA1509_16390} {RNA1310_7302.2} {RNA815_18232} |
| 62. | MligTC455_33813 | 325 | 6.77 | Mlig455_009548 | Neo: - Age: - |
MOXD1 | 1.713 | - | - | - | 0.719 | 0.994 | - | Mlig455_009548 {REF} {Length: 2790} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=105.1]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=67.2]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=130, Expect=5e-31]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=142, Expect=3e-35]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=116, Expect=7e-27]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=129, Expect=2e-31]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=119, Expect=3e-29]} {RNA1509_41983} {RNA1310_8990} {RNA815_3230} |
| 63. | MligTC455_45622 | 647 | 13.48 | Mlig455_069391 | Neo: - Age: - Region-specific R2: 5.132 Region-enriched R2: 3.915/0.00000 Regeneration-downregulated R2: -2.412 Regeneration-depleted R2: -2.412 |
1.711 | - | - | - | 0.721 | 0.990 | - | Mlig455_069391 {REF} {Length: 971} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982} {RNA1310_46295} {RNA815_23543} | |
| 64. | MligTC455_41854 | 80 | 1.67 | Mlig455_034307, Mlig455_067305, Mlig455_067321 | Neo: - Age: - |
1.708 | - | - | 0.722 | - | 0.986 | - | Mlig455_034307 {REF} {Length: 459} {RNA815_51696.1} Mlig455_067305 {REF} {Length: 466} {RNA815_51696.1} Mlig455_067321 {REF} {Length: 95} {TRANSSPLICED} {NoTransDecoderORF} {RNA815_51696.1} |
|
| 65. | MligTC455_11473 | 248 | 5.17 | Mlig455_009711, Mlig455_071036 | Neo: - Age: Down-Up-Down |
CHRNA3 | 1.706 | - | - | 0.754 | - | 0.952 | - | Mlig455_009711 {REF} {Length: 2402} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=241.4]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=391, Expect=2e-130]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=379, Expect=6e-126]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=375, Expect=2e-124]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=390, Expect=2e-130]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=375, Expect=2e-124]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [RH, Score=499, Expect=9e-173]} {Celegans: WBGene00000043, acr-3, Acetylcholine receptor subunit beta-type acr-3, [RH, Score=426, Expect=6e-145]} {Smed: dd_Smed_v6_12146_0_1, dd_Smed_v6_12146_0_1, [Score=510, Expect=1e-176]} {RNA1509_48201} {RNA1310_10118} {RNA815_29940} Mlig455_071036 {REF} {Length: 746} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.1]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=63.5, Expect=2e-13]} {Celegans: WBGene00000042, acr-2, Acetylcholine receptor subunit beta-type acr-2, [Score=63.9, Expect=9e-14]} {Smed: dd_Smed_v6_12535_0_1, dd_Smed_v6_12535_0_1, [Score=64.3, Expect=6e-14]} {RNA1310_21182} {RNA815_29940} |
| 66. | MligTC455_37058 | 19 | 0.4 | Mlig455_061075 | Neo: - Age: - |
1.706 | - | - | - | 0.741 | 0.965 | - | Mlig455_061075 {REF} {Length: 4598} {Pfam: IQ calmodulin-binding motif [PF00612.29, score=31.8]} {RNA1509_56135} {RNA1310_6435} {RNA815_17633} | |
| 67. | MligTC455_25412 | 199 | 4.15 | Mlig455_008720, Mlig455_063581 | Neo: - Age: - Region-enriched R2: 7.484/0.00035 |
CNBD2 | 1.705 | - | - | - | 0.720 | 0.985 | - | Mlig455_008720 {REF} {Length: 2602} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.1]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=1e-69]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} Mlig455_063581 {REF} {Length: 2668} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.3]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=7e-70]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} |
| 68. | MligTC455_27785 | 115 | 2.39 | Mlig455_001141 | Neo: - |
HMCN2 | 1.703 | - | - | - | 0.707 | 0.996 | - | Mlig455_001141 {REF} {Length: 2156} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=6e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_38050} {RNA1310_19586} {RNA815_17693} |
| 69. | MligTC455_32446 | 142 | 2.95 | Mlig455_042069 | Neo: - Age: Up-Down-Down |
TRPA1 | 1.703 | - | - | - | 0.749 | 0.954 | - | Mlig455_042069 {REF} {Length: 6835} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=191.2]; Ankyrin repeats (many copies) [PF13637.8, score=164.6]; Ankyrin repeats (many copies) [PF13857.8, score=152.4]; Ankyrin repeat [PF13606.8, score=136.2]; Ankyrin repeat [PF00023.32, score=129.7]; Ion transport protein [PF00520.33, score=47.4]} {Human: ENSG00000104321, TRPA1, transient receptor potential cation channel subfamily A member 1, [Score=176, Expect=1e-44]} {Mouse: ENSMUSG00000032769, Trpa1, transient receptor potential cation channel, subfamily A, member 1, [Score=286, Expect=4e-81]} {Dmel: FBgn0035934, TrpA1, Transient receptor potential cation channel A1, [Score=173, Expect=6e-44]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=450, Expect=2e-140]} {Smed: dd_Smed_v6_6201_0_1, dd_Smed_v6_6201_0_1, [Score=627, Expect=0.0]} {RNA1509_32186} {RNA1310_1780} {RNA815_450.1} |
| 70. | MligTC455_41106 | 42 | 0.88 | Mlig455_010275 | Neo: - Age: - Region-enriched R2: 5.386/0.03242 |
CALM1 | 1.703 | - | - | - | 0.737 | 0.966 | - | Mlig455_010275 {REF} {Length: 1557} {Pfam: EF hand [PF00036.34, score=32.5]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain [PF13405.8, score=29.3]} {Human: ENSG00000198668, CALM1, calmodulin 1, [Score=67.0, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=67.0, Expect=4e-14]; ENSG00000143933, CALM2, calmodulin 2, [Score=67.0, Expect=4e-14]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=67.0, Expect=3e-14]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=67.0, Expect=3e-14]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=3e-14]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.9, Expect=5e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=66.2, Expect=4e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=66.6, Expect=3e-14]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=66.6, Expect=2e-14]} {RNA1310_51265} |
| 71. | MligTC455_35124 | 780 | 16.25 | Mlig455_059030, Mlig455_070853 | Neo: - Age: Down-Up-Down Region-enriched R6: 6.026/0.00025 |
1.702 | - | - | - | 0.714 | 0.988 | - | Mlig455_059030 {REF} {Length: 944} {Pfam: Dynein light chain type 1 [PF01221.20, score=58.7]; EF-hand domain pair [PF13499.8, score=25.4]; EF hand [PF00036.34, score=21.8]; EF-hand domain [PF14658.8, score=20.5]; EF-hand domain [PF13405.8, score=19.8]} {Smed: dd_Smed_v6_6707_0_3, dd_Smed_v6_6707_0_3, [Score=128, Expect=6e-38]} {RNA1509_37636} {RNA1310_36928, RNA1509_37636} {RNA1509_37636, RNA815_25288} Mlig455_070853 {REF} {Length: 962} {Pfam: Dynein light chain type 1 [PF01221.20, score=58.8]; EF-hand domain pair [PF13499.8, score=25.6]; EF-hand domain [PF13405.8, score=21.1]; EF hand [PF00036.34, score=21.0]; EF-hand domain [PF14658.8, score=20.2]} {Smed: dd_Smed_v6_6707_0_3, dd_Smed_v6_6707_0_3, [Score=127, Expect=7e-38]} {RNA1509_37636} {RNA1310_36928} {RNA815_25288} |
|
| 72. | MligTC455_50437 | 8730 | 181.87 | Mlig455_042760 | Neo: - Age: logFC(26M/2M)=-0.331 Region-enriched R2: 1.062/0.03070 Regeneration-downregulated BL: -1.679 Regeneration-depleted BL: -1.679 |
1.702 | - | - | - | 0.737 | 0.965 | - | Mlig455_042760 {REF} {Length: 2445} {Pfam: SOR/SNZ family [PF01680.19, score=359.9]; Thiazole biosynthesis protein ThiG [PF05690.16, score=37.0]; Histidine biosynthesis protein [PF00977.23, score=21.5]; Dihydrouridine synthase (Dus) [PF01207.19, score=19.8]; Indole-3-glycerol phosphate synthase [PF00218.23, score=19.4]} {Smed: dd_Smed_v6_1240_0_1, dd_Smed_v6_1240_0_1, [RH, Score=441, Expect=1e-157]} {RNA1509_1321, RNA1509_1426, RNA1509_973} {RNA1310_25568, RNA1509_1321, RNA1509_1426, RNA1509_973} {RNA1509_1321, RNA1509_1426, RNA1509_973, RNA815_8446.1} | |
| 73. | MligTC455_53633 | 1960 | 40.84 | Mlig455_043831, Mlig455_047417, Mlig455_070992 | Neo: - Age: - Region-specific R2: 8.211 Region-enriched R2: 9.874/0.00000 |
1.702 | - | - | - | 0.706 | 0.996 | - | Mlig455_043831 {REF} {Length: 1456} {RNA1509_16856} {RNA1310_25970.1, RNA1509_16856} {RNA1509_16856, RNA815_11970} Mlig455_047417 {REF} {Length: 1354} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} Mlig455_070992 {REF} {Length: 1455} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} |
|
| 74. | MligTC455_42493 | 77 | 1.6 | Mlig455_033955 | Neo: - Age: - |
1.7 | - | - | 0.713 | - | 0.987 | - | Mlig455_033955 {REF} {Length: 878} {Smed: dd_Smed_v6_14508_0_1, dd_Smed_v6_14508_0_1, [RH, Score=75.9, Expect=3e-16]} {RNA1310_57572} | |
| 75. | MligTC455_23099 | 185 | 3.85 | Mlig455_048061 | Neo: - |
1.699 | - | - | - | 0.728 | 0.971 | - | Mlig455_048061 {REF} {Length: 713} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452} {RNA815_4585} | |
| 76. | MligTC455_33442 | 39 | 0.81 | Mlig455_039767 | Neo: - Age: - |
1.697 | - | - | - | 0.703 | 0.994 | - | Mlig455_039767 {REF} {Length: 1975} {RNA1310_42391} | |
| 77. | MligTC455_03731 | 113 | 2.35 | Mlig455_066791 | Neo: - Age: - |
1.695 | - | - | - | 0.709 | 0.986 | - | Mlig455_066791 {REF} {Length: 1679} {Smed: dd_Smed_v6_13648_0_1, dd_Smed_v6_13648_0_1, [RH, Score=79.7, Expect=2e-16]} {RNA1509_58026} {RNA1310_23180, RNA1509_58026} {RNA1509_58026, RNA815_34008} | |
| 78. | MligTC455_29432 | 12 | 0.25 | Mlig455_010925, Mlig455_033161 | Neo: - Age: Up-Down-Down |
STON2 | 1.694 | - | - | - | 0.710 | 0.984 | - | Mlig455_010925 {REF} {Length: 8069} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=150.8]} {Human: ENSG00000140022, STON2, stonin 2, [RH, Score=281, Expect=1e-77]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [RH, Score=283, Expect=5e-79]} {Dmel: FBgn0016975, stnB, stoned B, [RH, Score=381, Expect=2e-109]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [RH, Score=370, Expect=6e-104]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [RH, Score=774, Expect=0.0]} {RNA1509_18728} {RNA1310_1460} {RNA815_11684} Mlig455_033161 {REF} {Length: 6984} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=18.6]} {Human: ENSG00000140022, STON2, stonin 2, [Score=103, Expect=1e-21]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [Score=102, Expect=2e-21]} {Dmel: FBgn0016975, stnB, stoned B, [Score=124, Expect=4e-28]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [Score=144, Expect=3e-34]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [Score=375, Expect=3e-108]} {RNA1509_18728} {RNA1310_1460} {RNA815_11684} |
| 79. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 1.694 | - | - | - | 0.703 | 0.991 | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
| 80. | MligTC455_17138 | 283 | 5.89 | Mlig455_029728 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.646 Region-specific R2: 4.824 Region-enriched R2: 5.583/0.00000 |
LRRCC1 | 1.691 | - | - | - | 0.735 | 0.956 | - | Mlig455_029728 {REF} {Length: 1372} {Pfam: Heat shock factor binding protein 1 [PF06825.14, score=68.1]; Leucine Rich repeats (2 copies) [PF12799.9, score=67.8]; Leucine rich repeat [PF13855.8, score=44.9]; Leucine-rich repeat [PF14580.8, score=35.0]; Leucine Rich repeat [PF13516.8, score=21.5]} {Human: ENSG00000133739, LRRCC1, leucine rich repeat and coiled-coil centrosomal protein 1, [RH, Score=402, Expect=3e-122]} {Mouse: ENSMUSG00000027550, Lrrcc1, leucine rich repeat and coiled-coil domain containing 1, [RH, Score=387, Expect=3e-117]} {Dmel: FBgn0032429, CG5446, [Score=66.6, Expect=3e-13]} {Celegans: WBGene00189952, K10D2.8, [Score=65.1, Expect=8e-11]} {Smed: dd_Smed_v6_10086_0_1, dd_Smed_v6_10086_0_1, [RH, Score=443, Expect=2e-139]} {RNA1509_31405, RNA1509_32465} {RNA1310_70756, RNA1509_31405, RNA1509_32465} {RNA1509_31405, RNA1509_32465, RNA815_37567} |
| 81. | MligTC455_29725 | 72 | 1.49 | Mlig455_014390 | Neo: - Age: - Region-enriched R2: 7.905/0.00012 |
OTOP2 | 1.691 | - | - | 0.708 | - | 0.983 | - | Mlig455_014390 {REF} {Length: 2547} {Pfam: Otopetrin [PF03189.15, score=220.6]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=52.0, Expect=3e-06]; ENSG00000163982, OTOP1, otopetrin 1, [Score=49.7, Expect=1e-05]} {Mouse: ENSMUSG00000051596, Otop1, otopetrin 1, [Score=53.5, Expect=7e-07]; ENSMUSG00000050201, Otop2, otopetrin 2, [Score=51.6, Expect=3e-06]} {Dmel: FBgn0259150, CG42265, [Score=177, Expect=3e-46]} {Celegans: WBGene00017034, otpl-2, OToPetrin-Like, [Score=101, Expect=2e-22]} {Smed: dd_Smed_v6_13612_0_3, dd_Smed_v6_13612_0_3, [Score=276, Expect=7e-84]} {RNA1310_55206} {RNA815_48323} |
| 82. | MligTC455_53233 | 1483 | 30.9 | Mlig455_037746, Mlig455_069921 | Neo: - Age: - Region-specific R2: 7.323 Region-enriched R2: 7.524/0.00000 Regeneration-downregulated R2: -3.635 Regeneration-depleted R2: -3.635 |
PKD2 | 1.689 | - | - | - | 0.700 | 0.989 | - | Mlig455_037746 {REF} {Length: 3024} {Pfam: Polycystin cation channel [PF08016.14, score=468.5]; Ion transport protein [PF00520.33, score=85.9]; EF-hand domain pair [PF13499.8, score=21.3]; EF hand [PF00036.34, score=21.2]; EF-hand domain [PF13405.8, score=18.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=708, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=379, Expect=1e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=719, Expect=0.0]} {RNA1509_30624, RNA1509_6992} {RNA1310_6033, RNA1509_30624} {RNA1509_30624, RNA815_1577.1} Mlig455_069921 {REF} {Length: 3030} {Pfam: Polycystin cation channel [PF08016.14, score=467.0]; Ion transport protein [PF00520.33, score=85.5]; EF hand [PF00036.34, score=21.3]; EF-hand domain pair [PF13499.8, score=21.3]; EF-hand domain [PF13405.8, score=18.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=707, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=304, Expect=8e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=377, Expect=3e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=716, Expect=0.0]} {RNA1509_6992} {RNA1310_6033, RNA1509_6992} {RNA1509_6992, RNA815_1577.1} |
| 83. | MligTC455_15890 | 18 | 0.38 | Mlig455_059636 | Neo: - Age: - |
CD209 | 1.687 | - | - | - | 0.701 | 0.986 | - | Mlig455_059636 {REF} {Length: 1223} {Pfam: Lectin C-type domain [PF00059.23, score=29.7]} {Human: ENSG00000090659, CD209, CD209 molecule, [Score=49.3, Expect=2e-06]} {Dmel: FBgn0040096, lectin-33A, [Score=48.9, Expect=6e-07]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=64.7, Expect=2e-12]} {RNA1509_20946} {RNA1310_53178} {RNA815_42043} |
| 84. | MligTC455_32903 | 29 | 0.6 | Mlig455_037926 | Neo: - Age: - |
1.686 | - | - | - | 0.705 | 0.981 | - | Mlig455_037926 {REF} {Length: 1892} {RNA1310_57340} {RNA815_53132} | |
| 85. | MligTC455_47601 | 126 | 2.62 | Mlig455_056477 | Neo: - Age: Up-Down-Up |
NRXN1 | 1.684 | - | - | 0.711 | - | 0.973 | - | Mlig455_056477 {REF} {Length: 3481} {Pfam: Laminin G domain [PF02210.26, score=58.3]; Laminin G domain [PF00054.25, score=43.2]; Syndecan domain [PF01034.22, score=27.4]} {Human: ENSG00000179915, NRXN1, neurexin 1, [Score=142, Expect=4e-35]} {Mouse: ENSMUSG00000024109, Nrxn1, neurexin I, [Score=142, Expect=1e-35]} {Dmel: FBgn0038975, Nrx-1, Neurexin 1, [Score=102, Expect=2e-22]} {Smed: dd_Smed_v6_13697_0_1, dd_Smed_v6_13697_0_1, [Score=142, Expect=8e-36]} {RNA1509_55888} {RNA1310_37025, RNA1509_55888} {RNA1509_55888, RNA815_22404} |
| 86. | MligTC455_52814 | 47 | 0.97 | Mlig455_047356, Mlig455_047365 | Neo: - Age: - |
CNTN2 | 1.68 | - | - | - | 0.707 | 0.973 | - | Mlig455_047356 {REF} {Length: 2537} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=57.8]; Immunoglobulin domain [PF13927.8, score=52.6]; Immunoglobulin domain [PF13895.8, score=40.4]; Immunoglobulin domain [PF00047.27, score=40.3]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=25.9]} {Human: ENSG00000184144, CNTN2, contactin 2, [Score=58.5, Expect=3e-08]} {Mouse: ENSMUSG00000053024, Cntn2, contactin 2, [Score=56.6, Expect=8e-08]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=55.1, Expect=2e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=54.7, Expect=3e-07]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=58.2, Expect=2e-08]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [RH, Score=99.8, Expect=2e-22]} {RNA1509_60115} {RNA1310_31768} {RNA815_18728} Mlig455_047365 {REF} {Length: 3489} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=57.9]; Immunoglobulin domain [PF13927.8, score=52.8]; Immunoglobulin domain [PF13895.8, score=40.5]; Immunoglobulin domain [PF00047.27, score=40.3]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.4]} {Human: ENSG00000184144, CNTN2, contactin 2, [Score=57.4, Expect=5e-08]} {Mouse: ENSMUSG00000053024, Cntn2, contactin 2, [Score=55.5, Expect=1e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=53.9, Expect=5e-07]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=53.5, Expect=6e-07]; ENSMUSG00000055022, Cntn1, contactin 1, [Score=52.8, Expect=1e-06]; ENSMUSG00000030075, Cntn3, contactin 3, [Score=52.8, Expect=1e-06]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=55.5, Expect=1e-07]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [RH, Score=99.8, Expect=1e-22]} {RNA1509_60115} {RNA1310_31768} {RNA815_19521} |
| 87. | MligTC455_45913 | 4034 | 84.05 | Mlig455_017927 | Neo: - Age: Down-Up-Up Region-specific R2: 3.031 Region-enriched R2: 2.341/0.00000 Regeneration-downregulated BL: -1.976 Regeneration-depleted BL: -1.976 |
1.679 | - | - | 0.703 | - | 0.976 | - | Mlig455_017927 {REF} {Length: 1006} {RNA1509_22540, RNA1509_32903, RNA1509_3805} {RNA1310_38334, RNA1509_22540, RNA1509_32903, RNA1509_3805} {RNA1509_22540, RNA1509_32903, RNA1509_3805, RNA815_18393} | |
| 88. | MligTC455_44956 | 144 | 2.99 | Mlig455_061510 | Neo: - Age: - |
1.66 | - | - | 0.703 | - | 0.957 | - | Mlig455_061510 {REF} {Length: 493} {Pfam: Pancreatic hormone peptide [PF00159.20, score=31.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.8, Expect=9e-09]} {RNA1509_17163} {RNA1310_66833.1} {RNA815_41767} | |
| 89. | MligTC455_19252 | 1355 | 28.24 | Mlig455_054908, Mlig455_065614, Mlig455_065623 | Neo: - Age: Down-Down-Up Region-enriched R2: 4.927/0.00706 |
QPCT | 0.999 | - | - | - | - | 0.999 | - | Mlig455_054908 {REF} {Length: 1427} {Pfam: Peptidase family M28 [PF04389.19, score=84.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=113, Expect=3e-28]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=123, Expect=8e-32]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=116, Expect=7e-30]} {Celegans: WBGene00010418, H27A22.1, [Score=124, Expect=6e-33]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=118, Expect=1e-30]} {RNA1509_35784} {RNA1310_28475} Mlig455_065614 {REF} {Length: 1515} {Pfam: Peptidase family M28 [PF04389.19, score=121.0]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=157, Expect=2e-44]} {Mouse: ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=162, Expect=2e-46]; ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=161, Expect=6e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=158, Expect=2e-45]} {Celegans: WBGene00010418, H27A22.1, [Score=166, Expect=2e-48]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=156, Expect=2e-44]} {RNA1509_35784} {RNA1310_28475, RNA1509_35784} Mlig455_065623 {REF} {Length: 1295} {Pfam: Peptidase family M28 [PF04389.19, score=121.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=158, Expect=6e-45]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=162, Expect=2e-46]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=161, Expect=3e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=154, Expect=8e-44]} {Celegans: WBGene00010418, H27A22.1, [Score=163, Expect=2e-47]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=154, Expect=8e-44]} {RNA1509_35784} {RNA1310_28475} |
| 90. | MligTC455_01243 | 37 | 0.77 | Mlig455_055650 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_055650 {REF} {Length: 625} {Pfam: Universal stress protein family [PF00582.28, score=20.0]} {RNA1310_33871} {RNA815_28361} | |
| 91. | MligTC455_02149 | 10 | 0.21 | Mlig455_070095 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_070095 {REF} {Length: 1351} {RNA1509_31500} {RNA1310_687} {RNA815_17285} | |
| 92. | MligTC455_04854 | 57 | 1.18 | Mlig455_032030 | Neo: - Age: - Region-enriched R2: 5.099/0.03475 |
0.998 | - | - | - | - | 0.998 | - | Mlig455_032030 {REF} {Length: 1388} {RNA1310_84273} | |
| 93. | MligTC455_05668 | 5 | 0.09 | Mlig455_062596 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_062596 {REF} {Length: 36} {TRANSSPLICED} {NoTransDecoderORF} | |
| 94. | MligTC455_08512 | 8 | 0.17 | Mlig455_003206 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_003206 {REF} {Length: 422} {NoTransDecoderORF} | |
| 95. | MligTC455_09073 | 29 | 0.6 | Mlig455_001705 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_001705 {REF} {Length: 206} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_35647} | |
| 96. | MligTC455_09166 | 7 | 0.14 | Mlig455_036280, Mlig455_055473 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_036280 {REF} {Length: 226} {NoTransDecoderORF} {RNA1310_27375} {RNA815_35070} Mlig455_055473 {REF} {Length: 338} {NoTransDecoderORF} |
|
| 97. | MligTC455_11314 | 22 | 0.45 | Mlig455_008025 | Neo: - Age: - |
TRPC5 | 0.998 | - | - | - | - | 0.998 | - | Mlig455_008025 {REF} {Length: 3829} {Pfam: Transient receptor ion channel II [PF08344.13, score=100.2]; Ion transport protein [PF00520.33, score=93.1]; Polycystin cation channel [PF08016.14, score=32.4]; Ankyrin repeats (3 copies) [PF12796.9, score=30.9]; Ankyrin repeat [PF13606.8, score=23.9]; Ankyrin repeats (many copies) [PF13637.8, score=21.3]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [Score=632, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [Score=615, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [Score=634, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [Score=615, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [Score=598, Expect=0.0]} {Celegans: WBGene00006614, trp-1, Transient-receptor-potential-like protein, [RH, Score=820, Expect=0.0]} {Smed: dd_Smed_v6_15627_0_1, dd_Smed_v6_15627_0_1, [Score=559, Expect=0.0]} {RNA1310_93280} {RNA815_44973} |
| 98. | MligTC455_12991 | 30 | 0.62 | Mlig455_037487 | Neo: - Age: - |
CHRNA6 | 0.998 | - | - | - | - | 0.998 | - | Mlig455_037487 {REF} {Length: 1592} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=70.8]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=55.6]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=119, Expect=5e-29]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=110, Expect=4e-26]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=109, Expect=3e-25]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=107, Expect=5e-25]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=107, Expect=8e-25]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=106, Expect=2e-24]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=111, Expect=4e-26]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=111, Expect=1e-26]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=112, Expect=5e-27]} {RNA1310_100091} {RNA815_18433} |
| 99. | MligTC455_14360 | 15 | 0.31 | Mlig455_055751 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_055751 {REF} {Length: 814} {NoTransDecoderORF} {RNA1310_75499} {RNA815_32865} | |
| 100. | MligTC455_14498 | 3 | 0.06 | Mlig455_033728 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_033728 {REF} {Length: 1984} |
There are 768 more genes with r >= 0.95